{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:12:51Z","timestamp":1790334771602,"version":"4.1.0"},"reference-count":46,"publisher":"Zhejiang University Press","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1631\/jzus.b2200049","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T10:03:03Z","timestamp":1655892183000},"page":"451-460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Seasonal coronaviruses and SARS-CoV-2: effects of preexisting immunity during the COVID-19 pandemic","\u5b63\u8282\u6027\u51a0\u72b6\u75c5\u6bd2\u548cSARS-CoV-2:\u5728COVID-19\u75ab\u60c5\u4e2d\u9884\u5b58\u514d\u75ab\u7684\u5f71\u54cd"],"prefix":"10.1631","volume":"23","author":[{"given":"Gang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0848-1502","authenticated-orcid":false,"given":"Zhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"635","published-online":{"date-parts":[[2022,6,22]]},"reference":[{"issue":"7","key":"611_CR1","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1016\/j.cell.2021.02.010","volume":"184","author":"EM Anderson","year":"2021","unstructured":"Anderson EM, Goodwin EC, Verma A, et al., 2021. Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection. Cell, 184(7):1858\u20131864.e10. https:\/\/doi.org\/10.1016\/j.cell.2021.02.010","journal-title":"Cell"},{"issue":"2","key":"611_CR2","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.immuni.2021.01.008","volume":"54","author":"A Bonifacius","year":"2021","unstructured":"Bonifacius A, Tischer-Zimmermann S, Dragon AC, et al., 2021. COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses. Immunity, 54(2):340\u2013354.e6. https:\/\/doi.org\/10.1016\/j.immuni.2021.01.008","journal-title":"Immunity"},{"issue":"7833","key":"611_CR3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2598-9","volume":"587","author":"J Braun","year":"2020","unstructured":"Braun J, Loyal L, Frentsch M, et al., 2020. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature, 587(7833):270\u2013274. https:\/\/doi.org\/10.1038\/s41586-020-2598-9","journal-title":"Nature"},{"issue":"11","key":"611_CR4","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1056\/NEJMc070348","volume":"357","author":"WC Cao","year":"2007","unstructured":"Cao WC, Liu W, Zhang PH, et al., 2007. Disappearance of antibodies to SARS-associated coronavirus after recovery. N Engl J Med, 357(11):1162\u20131163. https:\/\/doi.org\/10.1056\/NEJMc070348","journal-title":"N Engl J Med"},{"issue":"2","key":"611_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41577-020-00480-0","volume":"21","author":"LP Dai","year":"2021","unstructured":"Dai LP, Gao GF, 2021. Viral targets for vaccines against COVID-19. Nat Rev Immunol, 21(2):73\u201382. https:\/\/doi.org\/10.1038\/s41577-020-00480-0","journal-title":"Nat Rev Immunol"},{"key":"611_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41467-020-20095-2","volume":"12","author":"RR de Assis","year":"2021","unstructured":"de Assis RR, Jain A, Nakajima R, et al., 2021. Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray. Nat Commun, 12:6. https:\/\/doi.org\/10.1038\/s41467-020-20095-2","journal-title":"Nat Commun"},{"key":"611_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41392-020-00338-w","volume":"5","author":"RD de Vries","year":"2020","unstructured":"de Vries RD, 2020. SARS-CoV-2-specific T-cells in unexposed humans: presence of cross-reactive memory cells does not equal protective immunity. Signal Transduct Tar Ther, 5:224. https:\/\/doi.org\/10.1038\/s41392-020-00338-w","journal-title":"Signal Transduct Tar Ther"},{"issue":"5","key":"611_CR8","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"ES Dong","year":"2020","unstructured":"Dong ES, Du HR, Gardner L, 2020. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis, 20(5):533\u2013534. https:\/\/doi.org\/10.1016\/S1473-3099(20)30120-1","journal-title":"Lancet Infect Dis"},{"key":"611_CR9","doi-asserted-by":"publisher","first-page":"m3563","DOI":"10.1136\/bmj.m3563","volume":"370","author":"P Doshi","year":"2020","unstructured":"Doshi P, 2020. Covid-19: do many people have pre-existing immunity? BMJ, 370:m3563. https:\/\/doi.org\/10.1136\/bmj.m3563","journal-title":"BMJ"},{"issue":"4","key":"611_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1631\/jzus.B2000730","volume":"22","author":"BH Feng","year":"2021","unstructured":"Feng BH, Zhang D, Wang Q, et al., 2021. Effects of angiotensin II receptor blocker usage on viral load, antibody dynamics, and transcriptional characteristics among COVID-19 patients with hypertension. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 22(4):330\u2013340. https:\/\/doi.org\/10.1631\/jzus.B2000730","journal-title":"J Zhejiang Univ-Sci B (Biomed & Biotechnol)"},{"key":"611_CR11","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3389\/fimmu.2020.01120","volume":"11","author":"W Fierz","year":"2020","unstructured":"Fierz W, Walz B, 2020. Antibody dependent enhancement due to original antigenic sin and the development of SARS. Front Immunol, 11:1120. https:\/\/doi.org\/10.3389\/fimmu.2020.01120","journal-title":"Front Immunol"},{"issue":"48","key":"611_CR12","doi-asserted-by":"publisher","first-page":"20365","DOI":"10.1073\/pnas.0911580106","volume":"106","author":"JA Greenbaum","year":"2009","unstructured":"Greenbaum JA, Kotturi MF, Kim Y, et al., 2009. Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci USA, 106(48):20365\u201320370. https:\/\/doi.org\/10.1073\/pnas.0911580106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"611_CR13","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"A Grifoni","year":"2020","unstructured":"Grifoni A, Weiskopf D, Ramirez SI, et al., 2020. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell, 181(7):1489\u20131501.e15. https:\/\/doi.org\/10.1016\/j.cell.2020.05.015","journal-title":"Cell"},{"issue":"10223","key":"611_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"CL Huang","year":"2020","unstructured":"Huang CL, Wang YM, Li XW, et al., 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"issue":"9","key":"611_CR15","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","volume":"41","author":"Y Huang","year":"2020","unstructured":"Huang Y, Yang C, Xu XF, et al., 2020. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin, 41(9):1141\u20131149. https:\/\/doi.org\/10.1038\/s41401-020-0485-4","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"611_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson CB, Farzan M, Chen B, et al., 2022. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol, 23(1):3\u201320. https:\/\/doi.org\/10.1038\/s41580-021-00418-x","journal-title":"Nat Rev Mol Cell Biol"},{"key":"611_CR17","doi-asserted-by":"publisher","unstructured":"Jia LQ, Weng SF, Wu J, et al., 2022. Pre-existing antibodies targeting a linear epitope on SARS-CoV-2 S2 cross-reacted with commensal gut bacteria and shaped vaccine induced immunity. medRxiv, prepint. https:\/\/doi.org\/10.1101\/2021.07.13.21260404","DOI":"10.1101\/2021.07.13.21260404"},{"key":"611_CR18","doi-asserted-by":"publisher","unstructured":"Kaplonek P, Wang CQ, Bartsch Y, et al., 2021. Early cross-coronavirus reactive signatures of protective humoral immunity against COVID-19. bioRxiv, prepint. https:\/\/doi.org\/10.1101\/2021.05.11.443609","DOI":"10.1101\/2021.05.11.443609"},{"key":"611_CR19","series-title":"Ninth Report of the International Committee on Taxonomy of Viruses","first-page":"770","volume-title":"Virus Taxonomy","author":"AMQ King","year":"2011","unstructured":"King AMQ, Adams MJ, Carstens EB, et al., 2011. Virus Taxonomy. Ninth Report of the International Committee on Taxonomy of Viruses. Elsevier, St. Louis, p.770\u2013783."},{"issue":"6493","key":"611_CR20","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1126\/science.abb5793","volume":"368","author":"SM Kissler","year":"2020","unstructured":"Kissler SM, Tedijanto C, Goldstein E, et al., 2020. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science, 368(6493):860\u2013868. https:\/\/doi.org\/10.1126\/science.abb5793","journal-title":"Science"},{"issue":"9","key":"611_CR21","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1371\/journal.pbio.0060226","volume":"6","author":"K Knoops","year":"2008","unstructured":"Knoops K, Kikkert M, van den Worm SHE, et al., 2008. SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol, 6(9):e226. https:\/\/doi.org\/10.1371\/journal.pbio.0060226","journal-title":"PLoS Biol"},{"key":"611_CR22","doi-asserted-by":"crossref","unstructured":"Kupferschmidt K, 2021. New coronavirus variants could cause more reinfections, require updated vaccines. Science COVID-19 Report. https:\/\/www.science.org\/content\/article\/new-coronavirus-variants-could-cause-more-reinfections-require-updated-vaccines [accessed on Jan. 15, 2021].","DOI":"10.1126\/science.abg6028"},{"issue":"8","key":"611_CR23","doi-asserted-by":"publisher","first-page":"e0256482","DOI":"10.1371\/journal.pone.0256482","volume":"16","author":"SA Lapp","year":"2021","unstructured":"Lapp SA, Edara VV, Lu A, et al., 2021. Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection. PLoS ONE, 16(8):e0256482. https:\/\/doi.org\/10.1371\/journal.pone.0256482","journal-title":"PLoS ONE"},{"issue":"9","key":"611_CR24","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/jama.2021.14181","volume":"326","author":"AS Lauring","year":"2021","unstructured":"Lauring AS, Malani PN, 2021. Variants of SARS-CoV-2. JAMA, 326(9):880\u2013880. https:\/\/doi.org\/10.1001\/jama.2021.14181","journal-title":"JAMA"},{"issue":"7821","key":"611_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","volume":"584","author":"N le Bert","year":"2020","unstructured":"le Bert N, Tan AT, Kunasegaran K, et al., 2020. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature, 584(7821):457\u2013462. https:\/\/doi.org\/10.1038\/s41586-020-2550-z","journal-title":"Nature"},{"issue":"10","key":"611_CR26","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41564-020-00789-5","volume":"5","author":"WS Lee","year":"2020","unstructured":"Lee WS, Wheatley AK, Kent SJ, et al., 2020. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol, 5(10):1185\u20131191. https:\/\/doi.org\/10.1038\/s41564-020-00789-5","journal-title":"Nat Microbiol"},{"issue":"D1","key":"611_CR27","doi-asserted-by":"publisher","first-page":"D708","DOI":"10.1093\/nar\/gkx932","volume":"46","author":"EJ Lefkowitz","year":"2018","unstructured":"Lefkowitz EJ, Dempsey DM, Hendrickson RC, et al., 2018. Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV). Nucl Acids Res, 46(D1):D708\u2013D717. https:\/\/doi.org\/10.1093\/nar\/gkx932","journal-title":"Nucl Acids Res"},{"issue":"8","key":"611_CR28","doi-asserted-by":"publisher","first-page":"e146316","DOI":"10.1172\/jci.insight.146316","volume":"6","author":"A Majdoubi","year":"2021","unstructured":"Majdoubi A, Michalski C, O\u2019Connell SE, et al., 2021. A majority of uninfected adults show preexisting antibody reactivity against SARS-CoV-2. JCI Insight, 6(8):e146316. https:\/\/doi.org\/10.1172\/jci.insight.146316","journal-title":"JCI Insight"},{"issue":"3","key":"611_CR29","doi-asserted-by":"publisher","first-page":"fuaa057","DOI":"10.1093\/femsre\/fuaa057","volume":"45","author":"JK Millet","year":"2021","unstructured":"Millet JK, Jaimes JA, Whittaker GR, 2021. Molecular diversity of coronavirus host cell entry receptors. FEMS Microbiol Rev, 45(3):fuaa057. https:\/\/doi.org\/10.1093\/femsre\/fuaa057","journal-title":"FEMS Microbiol Rev"},{"issue":"1","key":"611_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/iid3.367","volume":"9","author":"A Mveang Nzoghe","year":"2021","unstructured":"Mveang Nzoghe A, Essone PN, Leboueny M, et al., 2021. Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2. Immun, Inflamm Dis, 9(1):128\u2013133. https:\/\/doi.org\/10.1002\/iid3.367","journal-title":"Immun, Inflamm Dis"},{"issue":"6284","key":"611_CR31","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2016","unstructured":"Netea MG, Joosten LAB, Latz E, et al., 2016. Trained immunity: a program of innate immune memory in health and disease. Science, 352(6284):aaf1098. https:\/\/doi.org\/10.1126\/science.aaf1098","journal-title":"Science"},{"issue":"6522","key":"611_CR32","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1126\/science.abe1107","volume":"370","author":"KW Ng","year":"2020","unstructured":"Ng KW, Faulkner N, Cornish GH, et al., 2020. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science, 370(6522):1339\u20131343. https:\/\/doi.org\/10.1126\/science.abe1107","journal-title":"Science"},{"issue":"17","key":"611_CR33","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.vaccine.2016.02.063","volume":"34","author":"OW Ng","year":"2016","unstructured":"Ng OW, Chia A, Tan AT, et al., 2016. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection. Vaccine, 34(17):2008\u20132014. https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.063","journal-title":"Vaccine"},{"issue":"5","key":"611_CR34","doi-asserted-by":"publisher","first-page":"e01991","DOI":"10.1128\/mBio.01991-20","volume":"11","author":"P Nguyen-Contant","year":"2020","unstructured":"Nguyen-Contant P, Embong AK, Kanagaiah P, et al., 2020. S protein-reactive IgG and memory B cell production after human SARS-CoV-2 infection includes broad reactivity to the S2 subunit. mBio, 11(5):e01991\u201320. https:\/\/doi.org\/10.1128\/mBio.01991-20","journal-title":"mBio"},{"key":"611_CR35","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.1038\/s41467-021-24979-9","volume":"12","author":"N Ortega","year":"2021","unstructured":"Ortega N, Ribes M, Vidal M, et al., 2021. Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses. Nat Commun, 12: 4740. https:\/\/doi.org\/10.1038\/s41467-021-24979-9","journal-title":"Nat Commun"},{"issue":"1","key":"611_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41591-020-01143-2","volume":"27","author":"I Schulien","year":"2021","unstructured":"Schulien I, Kemming J, Oberhardt V, et al., 2021. Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells. Nat Med, 27(1):78\u201385. https:\/\/doi.org\/10.1038\/s41591-020-01143-2","journal-title":"Nat Med"},{"issue":"8","key":"611_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41577-020-0389-z","volume":"20","author":"A Sette","year":"2020","unstructured":"Sette A, Crotty S, 2020. Pre-existing immunity to SARS-CoV-2: the knowns and unknowns. Nat Rev Immunol, 20(8): 457\u2013458. https:\/\/doi.org\/10.1038\/s41577-020-0389-z","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"611_CR38","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1631\/jzus.B2000083","volume":"21","author":"Y Shi","year":"2020","unstructured":"Shi Y, Wang G, Cai XP, et al., 2020. An overview of COVID-19. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 21(5): 343\u2013360. https:\/\/doi.org\/10.1631\/jzus.B2000083","journal-title":"J Zhejiang Univ-Sci B (Biomed & Biotechnol)"},{"key":"611_CR39","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1038\/s41467-021-23074-3","volume":"12","author":"G Song","year":"2021","unstructured":"Song G, He WT, Callaghan S, et al., 2021. Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection. Nat Commun, 12:2938. https:\/\/doi.org\/10.1038\/s41467-021-23074-3","journal-title":"Nat Commun"},{"issue":"10","key":"611_CR40","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/nm.3350","volume":"19","author":"S Sridhar","year":"2013","unstructured":"Sridhar S, Begom S, Bermingham A, et al., 2013. Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med, 19(10):1305\u20131312. https:\/\/doi.org\/10.1038\/nm.3350","journal-title":"Nat Med"},{"key":"611_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-021-00596-2","volume":"6","author":"ZW Sui","year":"2021","unstructured":"Sui ZW, Dai XH, Lu QB, et al., 2021. Viral dynamics and antibody responses in people with asymptomatic SARS-CoV-2 infection. Signal Transduct Tar Ther, 6:181. https:\/\/doi.org\/10.1038\/s41392-021-00596-2","journal-title":"Signal Transduct Tar Ther"},{"issue":"10","key":"611_CR42","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1080\/21645515.2021.1945904","volume":"17","author":"VM Vashishtha","year":"2021","unstructured":"Vashishtha VM 2021. Is \u2018original antigenic sin\u2019 complicating Indian vaccination drive against Covid-19? Hum Vacc Immunother, 17(10):3314\u20133315. https:\/\/doi.org\/10.1080\/21645515.2021.1945904","journal-title":"Hum Vacc Immunother"},{"issue":"48","key":"611_CR43","doi-asserted-by":"publisher","first-page":"eabd2071","DOI":"10.1126\/sciimmunol.abd2071","volume":"5","author":"D Weiskopf","year":"2020","unstructured":"Weiskopf D, Schmitz KS, Raadsen MP, et al., 2020. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci Immunol, 5(48):eabd2071. https:\/\/doi.org\/10.1126\/sciimmunol.abd2071","journal-title":"Sci Immunol"},{"issue":"2","key":"611_CR44","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nm.2612","volume":"18","author":"TM Wilkinson","year":"2012","unstructured":"Wilkinson TM, Li CKF, Chui CSC, et al., 2012. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med, 18(2):274\u2013280. https:\/\/doi.org\/10.1038\/nm.2612","journal-title":"Nat Med"},{"issue":"7798","key":"611_CR45","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu F, Zhao S, Yu B, et al., 2020. A new coronavirus associated with human respiratory disease in China. Nature, 579(7798):265\u2013269. https:\/\/doi.org\/10.1038\/s41586-020-2008-3","journal-title":"Nature"},{"issue":"7798","key":"611_CR46","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, et al., 2020. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798):270\u2013273. https:\/\/doi.org\/10.1038\/s41586-020-2012-7","journal-title":"Nature"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2200049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1631\/jzus.B2200049\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2200049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T12:02:49Z","timestamp":1655899369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1631\/jzus.B2200049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["611"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b2200049","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"27 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}